ES2055719T3 - Derivados de desmanosil-teicoplanina. - Google Patents

Derivados de desmanosil-teicoplanina.

Info

Publication number
ES2055719T3
ES2055719T3 ES88110195T ES88110195T ES2055719T3 ES 2055719 T3 ES2055719 T3 ES 2055719T3 ES 88110195 T ES88110195 T ES 88110195T ES 88110195 T ES88110195 T ES 88110195T ES 2055719 T3 ES2055719 T3 ES 2055719T3
Authority
ES
Spain
Prior art keywords
derivatives
desmanosil
teicoplanine
nrrl
teicoplain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88110195T
Other languages
English (en)
Inventor
Angelo Borghi
Piero Antonini
Giancarlo Lancini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Application granted granted Critical
Publication of ES2055719T3 publication Critical patent/ES2055719T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365—Nocardia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/51—Streptomyces candidus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

EL OBJETO DE ESTE INVENTO SON LOS DERIVADOS TEICOPLAIN DE-MANNOSIT QUE PUEDEN SER OBTENIDOS EN BUENA PRODUCCION POR TRANSFORMACION MICROBIOLOGICA CON CULTIVOS DE NOCARDIA ORIENTALES NRRL 2450 O STREPTOWYES CANDIDUS NRRL 3228.
ES88110195T 1987-07-03 1988-06-27 Derivados de desmanosil-teicoplanina. Expired - Lifetime ES2055719T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878715735A GB8715735D0 (en) 1987-07-03 1987-07-03 De-mannosyl teicoplanin derivatives

Publications (1)

Publication Number Publication Date
ES2055719T3 true ES2055719T3 (es) 1994-09-01

Family

ID=10620077

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88110195T Expired - Lifetime ES2055719T3 (es) 1987-07-03 1988-06-27 Derivados de desmanosil-teicoplanina.

Country Status (13)

Country Link
US (1) US5064811A (es)
EP (1) EP0301247B1 (es)
JP (1) JPH0819155B2 (es)
KR (1) KR890002214A (es)
AT (1) ATE90731T1 (es)
CA (1) CA1334655C (es)
DE (1) DE3881775T2 (es)
DK (1) DK357488A (es)
ES (1) ES2055719T3 (es)
GB (1) GB8715735D0 (es)
HU (1) HU200488B (es)
IL (1) IL86895A (es)
ZA (1) ZA884577B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135857A (en) * 1987-07-03 1992-08-04 Gruppo Lepetit S.P.A. Process for the preparation of de-mannosyl teicoplanin derivatives
EP0376042B1 (en) * 1988-12-27 1996-03-13 GRUPPO LEPETIT S.p.A. Improved chemical process for preparing antibiotic L 17392 (deglucoteicoplanin) and its salts
US5500410A (en) * 1989-03-29 1996-03-19 Gruppo Lepetit S.P.A. Substituted alkylamide derivatives of teicoplanin
US5185320A (en) * 1989-04-03 1993-02-09 Gruppo Lepetit S.P.A. O56 -alkyl derivatives of aglycone and pseudo aglycones of teicoplanin
DK0448940T3 (da) 1990-03-28 1997-11-03 Lepetit Spa Fremgangsmåde til fremstilling af mannosylteicoplaninderivater og mannosylteicoplaninaglycon
WO1992010516A1 (en) * 1990-12-05 1992-06-25 Gruppo Lepetit S.P.A. 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
DE69633234T2 (de) * 1995-07-05 2005-09-15 Aventis Bulk S.P.A. Reinigung von dalbeheptide-antibiotika mittels isoelektrofokussierung
US5638609A (en) * 1995-11-13 1997-06-17 Manufacturing And Technology Conversion International, Inc. Process and apparatus for drying and heating
KR20000010589A (ko) 1996-04-23 2000-02-15 클라우디오 쿼르타 항생제a40926의아미드유도체의개선된화학적제조방법
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
AU2003294262B2 (en) * 2002-11-18 2007-08-23 Vicuron Pharmaceuticals Inc. Methods of administering dalbavancin for treatment of bacterial infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
WO2013061814A1 (ja) 2011-10-25 2013-05-02 株式会社パイロットコーポレーション 可逆熱変色性組成物
WO2015163421A1 (ja) 2014-04-24 2015-10-29 株式会社パイロットコーポレーション 可逆熱変色性スタンプ用インキ組成物及びスタンプ
CN107175968A (zh) * 2017-07-12 2017-09-19 重庆工业职业技术学院 一种大学生思想政治教育智能教学系统
EP3702419B1 (en) 2017-10-23 2023-09-20 Kabushiki Kaisha Pilot Corporation (also trading as Pilot Corporation) Reversible thermochromic aqueous ink composition and writing instrument using same
WO2020066650A1 (ja) 2018-09-25 2020-04-02 パイロットインキ株式会社 可逆熱変色性複合繊維
WO2020203603A1 (ja) 2019-03-29 2020-10-08 パイロットインキ株式会社 可逆熱変色性組成物、それを内包してなる可逆熱変色性マイクロカプセル顔料、及びそれを用いた筆記具
KR102804130B1 (ko) 2019-04-11 2025-05-09 가부시키가이샤 파이롯트 코포레이숀 가역 열 변색성 필기구용 수성 잉크 조성물, 그리고 그것을 내장한 리필 및 수성 볼펜
JPWO2024005057A1 (es) 2022-06-29 2024-01-04

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) * 1975-03-05 1977-12-30 Lepetit Spa Antibiotics
JPS5830037A (ja) * 1981-08-18 1983-02-22 Toshiba Corp 陰極線管の製造装置
FI73697C (fi) * 1982-06-08 1987-11-09 Lepetit Spa Foerfarande foer framstaellning av individuella faktorer 1, 2, 3, 4 och 5 av teikomysin a2.
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
AU579120B2 (en) * 1983-12-16 1988-11-17 Gruppo Lepetit S.P.A. Chemical process for preparing antibiotic L 17392 (deglucoteicoplanin) and its salts
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
US4694069A (en) * 1985-09-30 1987-09-15 Smithkline Beckman Corporation Kibdelosporangium aridum SK&F-AAD-609

Also Published As

Publication number Publication date
ZA884577B (en) 1989-04-26
JPH0819155B2 (ja) 1996-02-28
EP0301247A3 (en) 1990-07-11
DE3881775T2 (de) 1994-01-05
EP0301247A2 (en) 1989-02-01
IL86895A (en) 1993-04-04
GB8715735D0 (en) 1987-08-12
JPS6429398A (en) 1989-01-31
HU200488B (en) 1990-06-28
CA1334655C (en) 1995-03-07
DE3881775D1 (de) 1993-07-22
KR890002214A (ko) 1989-04-10
DK357488A (da) 1989-01-04
US5064811A (en) 1991-11-12
ATE90731T1 (de) 1993-07-15
IL86895A0 (en) 1988-11-30
HUT49379A (en) 1989-09-28
EP0301247B1 (en) 1993-06-16
DK357488D0 (da) 1988-06-29

Similar Documents

Publication Publication Date Title
DE69024965D1 (de) Dehydrodidemnin b
FI913169A0 (fi) Oligonukleotidanaloger med terminala 3'-3'- eller 5'-5'-internukleotidkopplingar.
MY104685A (en) Substituted thiazoles and their use as fungicides.
ATE90731T1 (de) De-mannosylteicoplanin-derivate.
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
ES2095926T5 (es) Cyclosporins.
DE69214438D1 (de) Mehrstufiger bestrahlungsprozess zur herstellung von zusammensetzungen auf acrylbasis, und derartig hergestellte zusammensetzungen
ES2170102T3 (es) Aminociclohexilesteres y utilizacion de los mismos.
AP9100310A0 (en) Tnf inhibitors
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
FR2651663B1 (fr) Article decoratif du genre composition florale ou vegetale.
DK0485229T3 (da) Vanddispergerbare granuler omfattende VA-mycorrhiza-svampe samt fremstilling og anvendelse deraf
EP0158212A3 (en) Citric-acid esters as blowing agents for working up plastics
ES2092981T3 (es) Derivados de aristeromicina/adenosina.
ATE128714T1 (de) Erythromycinderivate.
DE69124844D1 (de) Radicicol-Derivate, ihre Herstellung und ihre Antitumorwirkung
DE68911132D1 (de) Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils.
EP0237829A3 (en) Tetrahydro-3,4-furandiamine-n-n'-platinum complexes
ATE10204T1 (de) Saccharose-mutase, immobilisierte saccharosemutase und verwendung von dieser immobilisierten saccharose-mutase zur herstellung von isomaltulose (6-0-alpha-d-glucopyranosido-d- fructose).
DE3767728D1 (en) Hydroxylierte 1,2-diamincyclohexan platinkomplexe.
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
BR8700693A (pt) Expelentes de microbios fitopatogenicos e composicao expelente de microbios fitopatogenicos
ES2062332T3 (es) Benzoxazolonas antiinflamatorias.
ES8205218A1 (es) Un procedimiento para la preparacion de pirrolilpiperidinas utiles como agentes antidepresivo.
EP0310260A3 (en) Platinum complexes and their use as anti-tumor agents

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 301247

Country of ref document: ES